ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 883 • 2019 ACR/ARP Annual Meeting

    B Cell-specific MyD88 Regulates Pathology After Disease Onset in Murine Lupus

    Jeremy Tilstra1, Minjung Kim 1, Claire Leibler 1 and Mark Shlomchik 1, 1University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease defined by immune dysregulation, antibody formation, followed by end-organ damage. MyD88 is a central immune…
  • Abstract Number: 884 • 2019 ACR/ARP Annual Meeting

    Interferon-Alpha Disrupts Multiple B Cell Tolerance Mechanisms in 3H9 Mice

    Dario Ferri 1, Yuriy Baglaenko 2, Kieran Manion 3, Carolina Munoz-Grajales 4 and Joan Wither5, 1University Health Network, Toronto, ON, Canada, 2Brigham Woman's Hospital, Boston, 3Krembil Research Institute, Toronto, ON, Canada, 4University Health Network, Toronto, Canada, 5University Health Network, Krembil Research Institute, Toronto, ON, Canada

    Background/Purpose: Interferon-alpha (IFNα) is elevated in Systemic Lupus Erythematosus (SLE) and is thought to play a central role in its pathogenesis. Amongst IFNα’s many effects…
  • Abstract Number: 885 • 2019 ACR/ARP Annual Meeting

    TLR9 Signaling in HCV-Associated Atypical Memory B Cells Triggers Th1 and Rheumatoid Factor Autoantibody Responses

    Chloé COMARMOND1, Valerie Lorin 2, Cindy Marques 1, Anna Maciejewski-Duval 1, Nizar Joher 2, Cyril Planchais 2, Maxime Touzot 3, Thierry Hieu 2, Valentin Quiniou 1, Anne Desbois 4, Michelle Rosenzwajg 1, David Klatzmann 1, Patrice Cacoub 5, Hugo Mouquet 2 and David Saadoun 5, 1Assistance Publique des Hopitaux de Paris, PARIS, France, 2Institut Pasteur, PARIS, France, 3Institut Curie, Paris, France, 4GHPS, Paris, France, 5AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Paris, France

    Background/Purpose: Hepatitis C virus (HCV) infection contributes to the development of autoimmune disorders such as cryoglobulinemia vasculitis (CV). However, it remains unclear why only some…
  • Abstract Number: 886 • 2019 ACR/ARP Annual Meeting

    Mesenchymal Stem Cell Senescence Alleviates Their Chondrogenic and Seno-Suppressive Properties, Contributing to Osteoarthritis Development

    Olivier Malaise1, Yassin Tachikart 2, Michael Constantinides 2, Marcus Mumme 3, Daniele Noel 2, Jing Wang 4, Christian Jorgensen 2 and Jean-Marc brondello 2, 1GIGA Research, CHU and University of Liège, Liège, Belgium, 2IRMB, INSERM U1183, University of Montpellier, Montpellier, France, 3University Hospital of Basel, Basel, Switzerland, 4INM, INSERM U1050, University of Montpellier, Montpeller, France

    Background/Purpose: Tissue accumulation of p16INK4A-positive senescent cells is associated with age-related disorders such as osteoarthritis (OA). These senescent cells induce a tissue loss of function through…
  • Abstract Number: 887 • 2019 ACR/ARP Annual Meeting

    Critical Role of the Cholinergic System Involvement in Osteoarthritis

    Alice Courties1, Ariane Do 1, Sarah Leite 2, Audrey Pigenet 2, Morgane Belle 3, Geoffroy Nourissat 4, Alain Sautet 5, Alain Chedotal 3, Uwe Maskos 6, Francis Berenbaum 7 and Jérémie Sellam 1, 1Service de Rhumatologie, AP-HP Hôpital Saint-Antoine, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 2Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 3Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France, Paris, France, 4Chirurgie orthopédique, Clinique Maussins, Groupe Ramsay générale de santé, 67 rue de Romainville, 75019, Paris, Paris, France, 5Chirurgie orthopédique, AP-HP Hôpital Saint-Antoine, Paris, Paris, France, 6Unité de neurobiologie intégrative des systèmes cholinergiques, CNRS UMR 3571, Institut Pasteur, Paris, Paris, France, 7Sorbonne Université-Inserm CDR Saint-Antoine, AP-HP, Paris, France

    Background/Purpose: The efferent vagus nerve can regulate inflammation via its principal neurotransmitter acetylcholine (ACh), a concept referred as the 'cholinergic anti-inflammatory pathway'. ACh interacts with members of…
  • Abstract Number: 888 • 2019 ACR/ARP Annual Meeting

    Mitochondrial DNA Impact on Joint Degeneration Process Using DMM OA and Spontaneous Aging Conplastic Mice Models

    Morena Scotece1, Ignacio Rego-Pérez 2, Ana Victoria Lechuga-Vieco 3, María Concepción Jiménez Gómez 3, Purificación Filgueira-Fernández 4, José Antonio Enriquez 3 and Francisco J. Blanco 2, 1Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 3Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Madrid, Spain, 4Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Galicia, Spain

    Background/Purpose: Accumulated data indicated that osteoarthritis has a strong genetic component with a prevalent role of mitochondria and mtDNA variations. In the present work, we…
  • Abstract Number: 889 • 2019 ACR/ARP Annual Meeting

    Identification of Genetic Variants Associated with Erosive Hand Osteoarthritis Using Pedigrees from a State-Wide Population-Based Cohort

    Nikolas Kazmers1, Kendra Novak 1, Zhe Yu 2, Tyler Barker 3, Tyler Abraham 4, Robin Romero 4 and Michael Jurynec 1, 1University of Utah, Department of Orthopaedics, Salt Lake City, UT, 2Huntsman Cancer Institute - Utah Population Database Resource, Salt Lake City, UT, 3Intermountain Healthcare, Precision Genomics, Murray, UT, 4Intermountain Healthcare, Precision Genomics, St. George, UT

    Background/Purpose: Erosive osteoarthritis (EOA) of the hand is a characterized radiographically with centrally-located interphalangeal joint erosions, and clinically by its rapid onset, rapid rate of…
  • Abstract Number: 890 • 2019 ACR/ARP Annual Meeting

    Adenosine A2A Receptor Signaling Activates FoxO1 and FoxO3 and Promotes Cartilage Autophagy

    Benjamin Friedman1, Carmen Corciulo 2, Cristina Castro-Rivera 2 and Bruce Cronstein 2, 1Department of Medicine, Division of Rheumatology NYUSoM, NYC, 2NYU Langone, New York

    Background/Purpose: Osteoarthritis (OA) is a debilitating and costly condition caused by loss of articular cartilage secondary to chondrocyte dysfunction. Autophagy is a homeostatic pathway that…
  • Abstract Number: 891 • 2019 ACR/ARP Annual Meeting

    Lorecivivint (SM04690), a Potential Disease-Modifying Osteoarthritis Drug, Inhibits CLK2 and DYRK1A, Novel Molecular Regulators of Wnt Signaling, Chondrogenesis, and Inflammation

    Vishal Deshmukh1, Alyssa O'Green 1, Carine Bossard 1, Tim Seo 1, Lisa Lamangan 1, Maureen Ibanez 1, Abdullah Ghias 1, Carolyn Lai 1, Long Do 1, Shawn Cho 1, Joseph Cahiwat 1, Kevin Chiu 1, Melinda Pedraza 1 and Yusuf Yazici 1, 1Samumed, LLC, San Diego, CA

    Background/Purpose: In the synovial joint, Wnt pathway upregulation contributes to osteoarthritis (OA) by increasing osteocyte differentiation, cartilage thinning, and inflammation. Lorecivivint (LOR; SM04690), a novel…
  • Abstract Number: 892 • 2019 ACR/ARP Annual Meeting

    Adverse Childhood Experiences Are Associated with Systemic Lupus Erythematosus in a Clinical Population from Bronx, New York

    Roberto Valdovinos1, Nicole Brown 2, Miguelina Germán 2, Qi Gao 3, Kaye Brathwaite 2, Kimberly Reidy 2, Dawn Wahezi 4, Chaim Putterman 5, Ruth E. Stein 2 and Tamar Rubinstein 6, 1Albert Einstein College of Medicine, Philadelphia, PA, 2Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, 3Albert Einstein College of Medicine, Bronx, 4Children’s Hospital at Montefiore, New York, 5Albert Einstein College of Medicine, New York, NY, 6Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Adverse Childhood Experiences (ACEs), which can result in chronic stress, are associated with autoimmune diseases in adulthood and arthritis in childhood. Recently ACEs were…
  • Abstract Number: 893 • 2019 ACR/ARP Annual Meeting

    The Presence of Extractable Nuclear Antigens (ENA) Antibodies in a Large Population-based Cohort from the Netherlands and Their Association with Known Risk Factors for Systemic Lupus Erythematosus and Primary Sjögren Syndrome

    Petra Yntema-Eckenhaussen 1, Suzanne Arends 1, Elisabeth Brouwer 2, Caroline Roozendaal 3, Hendrika Bootsma 4, Johanna Westra 1 and Karina de Leeuw1, 1Dept. of Rheumatology and Clinical Immunology - University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands, 2Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Dept. of Laboratory Medicine - University Medical Center Groningen (UMCG), University of Groningen, Groningen, Netherlands, 4University of Groningen, Groningen, Netherlands

    Background/Purpose: Previous studies have demonstrated that years before clinical onset of auto-immune diseases, auto-antibodies can already be present. However, it is also known that some…
  • Abstract Number: 894 • 2019 ACR/ARP Annual Meeting

    Frequency, Severity and Costs of Flares Increase with Disease Severity in Newly Diagnosed Systematic Lupus Erythematous: A Real-World Cohort Study, United States, 2004–2015

    Miao Jiang 1, Barnabas Desta 1, Aimee Near 2, Xia Wang 1 and Edward Hammond1, 1AstraZeneca, Gaithersburg, MD, 2IQVIA, Durham, NC

    Background/Purpose: We evaluated the real-world frequency and severity of flares and associated costs 1 year post diagnosis in a US cohort with newly diagnosed SLE.Methods:…
  • Abstract Number: 895 • 2019 ACR/ARP Annual Meeting

    A Spatial-temporal Analysis of Organ-specific Lupus Flares in Relation to Fine Particulate Matter Pollution and Temperature

    George Stojan1, Anton Kvit 2, Frank Curriero 2 and Michelle Petri 3, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, 3Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: We performed a spatial-time cluster analysis of the Hopkins Lupus Cohort with the goal of identifying potential clusters of SLE organ specific flares and…
  • Abstract Number: 896 • 2019 ACR/ARP Annual Meeting

    Hydroxychloroquine Use and Cardiovascular Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    April Jorge1, Na Lu 2, Hyon K. Choi 1, John Esdaile 3, Diane Lacaille 4 and J. Antonio Avina-Zubieta 5, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hosptial, Boston, MA, 3Arthritis Research Canada and the University of British Columbia, Richmond, BC, Canada, 4Arthritis Research Canada and University of British Columbia, Vancouver, BC, Canada, 5Arthritis Research Canada and the University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Hydroxychloroquine (HCQ) is near-universally recommended for patients with SLE and is often used in the treatment of RA. Use of HCQ has been associated…
  • Abstract Number: 897 • 2019 ACR/ARP Annual Meeting

    Mortality Rates After Coronary Revascularization Procedures Among Systemic Lupus Erythematosus Compared to Diabetes Mellitus and General Population Medicaid Patients

    Medha Barbhaiya1, Sarah Chen 2, Candace Feldman 3, Hongshu Guan 3, Brendan Everett 4 and Karen Costenbader 4, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Brigham and Women's Hospital and Harvard Medical School, Boston, 3Brigham and Women's Hospital, Boston, 4Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Despite similar myocardial infarction risks in SLE and diabetes mellitus (DM) patients, individuals with SLE enrolled in Medicaid had substantially higher rates of coronary…
  • « Previous Page
  • 1
  • …
  • 997
  • 998
  • 999
  • 1000
  • 1001
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology